Delivery Order SPE2DB20D2104-SPE2DB25FMTVM
Award Date
6/23/25
Potential Completion Date
6/24/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $91,735.56, is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a $32,845.11 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of 4,565,309,996 units of the pharmaceutical product GEMTESA 75 MG TABLET 90S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for the delivery of a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,429.36 firm fixed-price contract is for the supply of GEMTESA 75 MG TABLET 30S, a prescription medication. The contract is not designated with a set-aside requirement, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,652.12, is for the delivery of 4,568,059,839 units of the medication GEMTESA 75 MG TABLET 90S. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a Delivery Order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is for the medical supply item "GEMTESA 75 MG TABLET 30S" and has a ceiling value of $1,164.10. The contract is Firm Fixed Price and has an ultimate completion date of July 10, 2024. This Delivery Order is issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The contract has a ceiling value of $30,348.20 and a period of performance through September 7, 2023. The contract is not set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of GEMTESA 75 MG TABLET 90S. The firm-fixed-price delivery order, valued at $6,347.68, was issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC, valued up to $999,999,999, provides a vehicle for AmerisourceBergen to deliver a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, to support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,655.37 contract is for the supply of GEMTESA 75 MG TABLET 90S, a prescription medication, with a period of performance through April 2025. The contract is not set aside and was openly competed. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,823.43, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of May 12, 2025. The award is not set-aside and was competed openly. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract has a ceiling value of $3,920.01 and is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...